home · filing · 0001104659-26-035274
8-K
filed Mar 26, 2026 23:59 UTC
CIK 0000846475
other_material
confidence high
sentiment negative
materiality 1.00
Zynex emerges from Chapter 11; all common stock canceled, $10M exit loan, new board
ZYNEX INC
Old common stock canceled; Plan Sponsor Altivera Medical Holdings receives 100% of 1,000 new shares.
Exit Credit Agreement provides $10.0M senior secured term loan due 2034, convertible to common stock.
DIP facility ($22.3M) and $60M 5% Convertible Senior Notes discharged on Effective Date.
New board: Vikram Bajaj and John Bibb as directors; officers remain in same capacities.
Articles amended to authorize 1M shares of $0.001 par common stock, no other classes.
item 1.01 item 1.02 item 2.03 item 3.02 item 3.03 item 5.01 item 5.02 item 5.03 item 9.01
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
John Bibb
Director
ZYNEX INC
Filed Mar 26, 2026 23:59 UTC
Vikram Bajaj and John Bibb were appointed as directors of the Company.
Appointed
Vikram Bajaj
Director
ZYNEX INC
Filed Mar 26, 2026 23:59 UTC
Vikram Bajaj and John Bibb were appointed as directors of the Company.
Source: SEC EDGAR
accession 0001104659-26-035274
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.